SCHEMBL3950772

SCHEMBL3950772

O=[C]NCCCC1CCN(CCCC2CCOC2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.32
NAMPT P43490 1/20 0.32
CHRM2 P08172 3/20 0.32
CHRM4 P08173 3/20 0.32
CHRM5 P08912 3/20 0.32
CHRM1 P11229 3/20 0.32
CHRM3 P20309 3/20 0.32
DRD4 P21917 3/20 0.31
SIGMAR1 Q99720 1/20 0.31
S1PR5 Q9H228 1/20 0.30
DRD2 P14416 2/20 0.30
DRD3 P35462 2/20 0.30
GNAO1 P09471 1/20 0.30
LMNA P02545 1/20 0.30
ADRB2 P07550 1/20 0.30
ADRB1 P08588 1/20 0.30
ADRA1D P25100 1/20 0.30
ADRA1A P35348 1/20 0.30
ADRA1B P35368 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3950698 0.95 ALDH1A1 (0.34) ALDH1A1NAMPTDRD4SIGMAR1DRD2
SCHEMBL3949391 0.93 ALDH1A1 (0.41) ALDH1A1GAACHRM2CHRM4CHRM5
SCHEMBL3950837 0.88 ALDH1A1 (0.39) ALDH1A1SIGMAR1DRD2DRD3LMNA
SCHEMBL3949679 0.82 CHRM5 (0.38) ALDH1A1GAACHRM2CHRM4CHRM5
SCHEMBL3950776 0.82 ALDH1A1 (0.36) ALDH1A1GAANAMPTCHRM2CHRM4
SCHEMBL3951164 0.81 ALDH1A1 (0.33) ALDH1A1GAAGNAO1
SCHEMBL3949506 0.80 ALDH1A1 (0.35) ALDH1A1GAANAMPTCHRM2CHRM4
SCHEMBL3950123 0.79 ALDH1A1 (0.32) ALDH1A1S1PR5
SCHEMBL3950074 0.79 ALDH1A1 (0.32) ALDH1A1GAAS1PR5
SCHEMBL3950649 0.79 CHRM1 (0.40) ALDH1A1CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009024825-A1 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed